Newtown, PA, United States of America

Thomas P Markotan

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas P Markotan. Retrieved from https://idiyas.com/inventor/thomas-p-markotan-v1i32bwb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Thomas P Markotan

Introduction

Thomas P Markotan is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing innovative therapeutic compositions and methods that enhance treatment efficacy.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses." This patent discloses compositions that include a diastereomer of a macrolide, which exhibits an improved therapeutic profile in inhibiting cell proliferation compared to mixtures of diastereomers. Additionally, it provides drug-ligand conjugates formed using the diastereomer and outlines a novel method for preparing the diastereomer along with its therapeutic applications. Another significant patent is "Maytansinoid derivatives, conjugates thereof, and methods of use." This invention presents maytansinoid compounds, their derivatives, and conjugates, along with methods for treating or preventing proliferative diseases.

Career Highlights

Thomas P Markotan is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His expertise and dedication to research have led to advancements that could potentially transform treatment methodologies.

Collaborations

Throughout his career, Markotan has collaborated with esteemed colleagues, including Thomas Nittoli and Nareshkumar Jain. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Thomas P Markotan's contributions to pharmaceutical innovations are noteworthy, with a focus on improving therapeutic outcomes through his patented inventions. His work exemplifies the impact of dedicated research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…